GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4R(1)(a) and (c) I give details of changes in the interests of the following Directors and Persons Discharging Managerial Responsibilities ('PDMR') who acquired Ordinary Shares ('Shares') in GlaxoSmithKline plc ('GSK') at a price of 1294.81 pence per Share, following the re-investment of the dividend paid to shareholders on 1 October 2015.
|
Director/PDMR
|
Shares |
|
Sir Andrew Witty
|
29.783 |
|
Mr R G Connor |
247.313 |
|
Mr S Dingemans |
975.733 |
|
Mr S A Hussain |
2,232.502 |
|
Mr D S Redfern |
846.893 |
|
Dr M M Slaoui |
171.202 |
|
Ms C Thomas |
1,039.600 |
|
Mr P C Thomson |
355.850 |
|
Dr P J T Vallance
|
1,260.356 |
|
Ms E Walmsley
|
977.510 |
|
Connected Person |
Shares |
|
Mrs K Thomson (Connected Person to Mr P C Thomson)
|
114.588 |
GSK was informed of these allocations on 16 October 2015.
V A Whyte
Company Secretary
19 October 2015